TRAIL-receptor 2—a novel negative regulator of p53
Anna Willms, Anna Trauzold(Christian-Albrechts-Universität zu Kiel)
Cited by 19
Related Papers
Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells
|PLoS ONE|2019|50
The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells
|Cell Death and Disease|2018|40
Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
|Frontiers in Cell and Developmental Biology|2022|4